Isolated nucleic acid molecule encoding cancer associated antigens, the antigens per se, and uses thereof
CA 2324975 A1 · Owner: Stockert, Elisabeth · Inventors: Tsang, Solam; Knuth, Alexander; Old, Lloyd, J.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to newly identified cancer associated antigens referred , to as CT7, KOC-2 and KOC-3. The invention also relates to observations regarding known molecule KOC-1. It has been discovered that each of these molecules provokes antibodies when expressed by a subject. The ramifications of this observation are also a part of this invention.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 16, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 16, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 16, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.